University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > Thomas Ports

Thomas Ports, M.D.

Director of Interventional Cardiology

Dr. Thomas Ports is director of Interventional Cardiology and co-director of the Cardiac Catheterization Laboratory for adult patients. Since performing the first coronary angioplasty at UCSF Medical Center in 1979, he has accumulated vast experience in performing catheter interventions. In addition to elective angioplasty, he specializes in the treatment of acute myocardial infarction in the Cardiac Catheterization Laboratory, balloon valvuloplasty of stenotic valves and alcohol septal ablation in obstructive cardiomyopathy. Ports, a professor of medicine at UCSF, is called upon frequently to give second opinions in difficult cases.

Clinics

Cardiovascular Care and Prevention Center at Mission Bay
535 Mission Bay Blvd. South
San Francisco, CA 94158
Phone: (415) 353-2873
Fax: (415) 353-2528

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

More about Thomas Ports

Education

Ohio State University School of Medicine 1973

Residencies

University of Chicago Hospital, Internal Medicine 1976

Fellowships

UCSF Medical Center, Cardiology 1978

Selected Research and Publications

  1. Zellner C, Ports TA, Yeghiazarians Y, Boyle AJ. Sterile radial artery granuloma after transradial procedures: a unique and avoidable complication. Catheter Cardiovasc Interv. 2010 Nov 1; 76(5):673-6.
  2. Yong CM, Sharma M, Ochoa V, Abnousi F, Roberts J, Bass NM, Niemann CU, Shiboski S, Prasad M, Tavakol M, Ports TA, Gregoratos G, Yeghiazarians Y, Boyle AJ. Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation. Liver Transpl. 2010 Nov; 16(11):1242-8.
  3. Zellner C, Yeghiazarians Y, Ports TA, Ursell P, Boyle AJ. Sterile radial artery granuloma after transradial cardiac catheterization. Cardiovasc Revasc Med. 2011 May-Jun; 12(3):187-9.
  4. Sharma M, Yong C, Majure D, Zellner C, Roberts JP, Bass NM, Ports TA, Yeghiazarians Y, Gregoratos G, Boyle AJ. Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation. Am J Cardiol. 2009 Mar 1; 103(5):742-6.
  5. Mishell JM, Vakharia KT, Ports TA, Yeghiazarians Y, Michaels AD. Determination of adequate coronary stent expansion using StentBoost, a novel fluoroscopic image processing technique. Catheter Cardiovasc Interv. 2007 Jan; 69(1):84-93.
  6. Klein A, Lee K, Gera A, Ports TA, Michaels AD. Long-term mortality, cause of death, and temporal trends in complications after percutaneous aortic balloon valvuloplasty for calcific aortic stenosis. J Interv Cardiol. 2006 Jun; 19(3):269-75.
  7. Akhtar M, Vakharia KT, Mishell J, Gera A, Ports TA, Yeghiazarians Y, Michaels AD. Randomized study of the safety and clinical utility of rotational vs. standard coronary angiography using a flat-panel detector. Catheter Cardiovasc Interv. 2005 Sep; 66(1):43-9.
  8. Boltwood CM, Chien W, Ports T. Ventricular tachycardia complicating alcohol septal ablation. N Engl J Med. 2004 Oct 28; 351(18):1914-5.
  9. Dauterman KW, Michaels AD, Ports TA. Is there any indication for aortic valvuloplasty in the elderly? Am J Geriatr Cardiol. 2003 May-Jun; 12(3):190-6.
  10. Michaels AD, Accad M, Ports TA, Grossman W. Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation. Circulation. 2002 Sep 3; 106(10):1237-42.
  11. Michaels AD, Appleby M, Otten MH, Dauterman K, Ports TA, Chou TM, Gibson CM. Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial. J Invasive Cardiol. 2002 Jun; 14(6):299-302.
  12. Michaels AD, Ports TA. Use of a percutaneous arterial suture device (Perclose) in patients undergoing percutaneous balloon aortic valvuloplasty. Catheter Cardiovasc Interv. 2001 Aug; 53(4):445-7.
  13. Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, Sparler S, Armstrong WT, Ports TA, Kirkeeide RL, Hogeboom C, Brand RJ. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998 Dec 16; 280(23):2001-7.
  14. Whisenant B, Sweeney J, Ports TA. Combined PTCA and aortic valvuloplasty for acute myocardial infarction complicated by severe aortic stenosis and cardiogenic shock. Cathet Cardiovasc Diagn. 1997 Nov; 42(3):283-5.
  15. Drew BJ, Adams MG, McEldowney DK, Lau KY, Wung SF, Wolfe CL, Ports TA, Chou TM. Frequency, duration, magnitude, and consequences of myocardial ischemia during intracoronary ultrasonography. Am Heart J. 1997 Sep; 134(3):474-8.
  16. Denardo SJ, Talbot L, Hargrave VK, Selfridge AR, Ports TA, Yock PG. Accuracy of Doppler catheter measurements: effect of inhomogeneous beam power distribution on mean and peak velocity. J Am Coll Cardiol. 1997 Feb; 29(2):283-92.
  17. Heidenreich PA, Chou TM, Amidon TM, Ports TA, Browner WS. Impact of the operating physician on costs of percutaneous transluminal coronary angioplasty. Am J Cardiol. 1996 Jun 1; 77(14):1169-73.
  18. Hausmann D, Johnson JA, Sudhir K, Mullen WL, Friedrich G, Fitzgerald PJ, Chou TM, Ports TA, Kane JP, Malloy MJ, Yock PG. Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: correlation with high density lipoproteins. J Am Coll Cardiol. 1996 Jun; 27(7):1562-70.
  19. Chou TM, Amidon TM, Ports TA, Wolfe CL. Cardiogenic shock: thrombolysis or angioplasty? J Intensive Care Med. 1996 Jan-Feb; 11(1):37-48.
  20. Heidenreich PA, Chou TM, Smedira NG, Sweeney JP, Schiller NB, Schwartz DE, Merrick SH, Ports TA. Catheter fragmentation of massive pulmonary embolus: guidance with transesophageal echocardiography. Am Heart J. 1995 Dec; 130(6):1306-8.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2013 The Regents of The University of California